Literature DB >> 24938433

Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression.

Feng Huang1, Mei Wang, Tingting Yang, Jie Cai, Qiang Zhang, Zixuan Sun, Xiaodan Wu, Xu Zhang, Wei Zhu, Hui Qian, Wenrong Xu.   

Abstract

PURPOSE: This study was designed to investigate the role of PDGF-DD secreted by gastric cancer-derived mesenchymal stem cells (GC-MSCs) in human gastric cancer progression.
METHODS: Gastric cancer cells were indirectly co-cultured with GC-MSCs in a transwell system. The growth and migration of gastric cancer cells were evaluated by cell colony formation assay and transwell migration assay, respectively. The production of PDGF-DD in GC-MSCs was determined by using Luminex and ELISA. Neutralization of PDGFR-β by su16f and siRNA interference of PDGF-DD in GC-MSCs was used to demonstrate the role of PDGF-DD produced by GC-MSCs in gastric cancer progression.
RESULTS: GC-MSC conditioned medium promoted gastric cancer cell proliferation and migration in vitro and in vivo. Co-culture with GC-MSCs increased the phosphorylation of PDGFR-β in SGC-7901 cells. Neutralization of PDGFR-β by su16f blocked the promoting role of GC-MSC conditioned medium in gastric cancer cell proliferation and migration. Recombinant PDGF-DD duplicated the effects of GC-MSC conditioned medium on gastric cancer cells. Knockdown of PDGF-DD in GC-MSCs abolished its effects on gastric cancer cells in vitro and in vivo.
CONCLUSIONS: PDGF-DD secreted by GC-MSCs is capable of promoting gastric cancer cell progression in vitro and in vivo. Targeting the PDGF-DD/PDGFR-β interaction between MSCs and gastric cancer cells may represent a novel strategy for gastric cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24938433     DOI: 10.1007/s00432-014-1723-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  34 in total

1.  Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.

Authors:  T Kinnaird; E Stabile; M S Burnett; C W Lee; S Barr; S Fuchs; S E Epstein
Journal:  Circ Res       Date:  2004-01-22       Impact factor: 17.367

2.  Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo.

Authors:  Wei Zhu; Wenrong Xu; Runqiu Jiang; Hui Qian; Miao Chen; Jiabo Hu; Weike Cao; Chongxu Han; Yongchang Chen
Journal:  Exp Mol Pathol       Date:  2005-10-07       Impact factor: 3.362

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.

Authors:  Michael Quante; Shui Ping Tu; Hiroyuki Tomita; Tamas Gonda; Sophie S W Wang; Shigeo Takashi; Gwang Ho Baik; Wataru Shibata; Bethany Diprete; Kelly S Betz; Richard Friedman; Andrea Varro; Benjamin Tycko; Timothy C Wang
Journal:  Cancer Cell       Date:  2011-02-15       Impact factor: 31.743

Review 5.  The gastrointestinal tumor microenvironment.

Authors:  Michael Quante; Julia Varga; Timothy C Wang; Florian R Greten
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

Review 6.  PDGF-D signaling: a novel target in cancer therapy.

Authors:  Zhiwei Wang; Dejuan Kong; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2009-01       Impact factor: 3.465

7.  CD105-positive cells in pulmonary arterial blood of adult human lung cancer patients include mesenchymal progenitors.

Authors:  Haruki Chiba; Genicihro Ishii; Ta-Kashi Ito; Kazuhiro Aoyagi; Hiroki Sasaki; Kanji Nagai; Atsushi Ochiai
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277

8.  Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).

Authors:  F T Martin; R M Dwyer; J Kelly; S Khan; J M Murphy; C Curran; N Miller; E Hennessy; P Dockery; F P Barry; T O'Brien; M J Kerin
Journal:  Breast Cancer Res Treat       Date:  2010-01-20       Impact factor: 4.872

9.  Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma.

Authors:  Sylwia Ammoun; Christine Flaiz; Natalia Ristic; Jennifer Schuldt; C Oliver Hanemann
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

View more
  18 in total

Review 1.  Targeting platelet-derived growth factor (PDGF) signaling in gastrointestinal cancers: preclinical and clinical considerations.

Authors:  Omar Abdel-Rahman
Journal:  Tumour Biol       Date:  2014-11-14

2.  Curcumin inhibits gastric cancer-derived mesenchymal stem cells mediated angiogenesis by regulating NF-κB/VEGF signaling.

Authors:  Feng Huang; Yongliang Yao; Jianhong Wu; Qingqian Liu; Jiao Zhang; Xiongyong Pu; Qiang Zhang; Longfei Xia
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

3.  Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?

Authors:  Banu Iskender; Kenan Izgi; Cagri Sakalar; Halit Canatan
Journal:  Tumour Biol       Date:  2015-09-03

4.  YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression.

Authors:  Zhaoji Pan; Yiqing Tian; Bin Zhang; Xu Zhang; Hui Shi; Zhaofeng Liang; Peipei Wu; Rong Li; Benshuai You; Lunyu Yang; Fei Mao; Hui Qian; Wenrong Xu
Journal:  Int J Oncol       Date:  2017-08-23       Impact factor: 5.650

5.  Mesenchymal stromal cells' role in tumor microenvironment: involvement of signaling pathways.

Authors:  Armel Herve Nwabo Kamdje; Paul Takam Kamga; Richard Tagne Simo; Lorella Vecchio; Paul Faustin Seke Etet; Jean Marc Muller; Giulio Bassi; Erique Lukong; Raghuveera Kumar Goel; Jeremie Mbo Amvene; Mauro Krampera
Journal:  Cancer Biol Med       Date:  2017-05       Impact factor: 4.248

6.  Discovery of Prognostic Signature Genes for Overall Survival Prediction in Gastric Cancer.

Authors:  Changyuan Meng; Shusen Xia; Yi He; Xiaolong Tang; Guangjun Zhang; Tong Zhou
Journal:  Comput Math Methods Med       Date:  2020-08-25       Impact factor: 2.238

7.  Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5.

Authors:  Gen Nishikawa; Kenji Kawada; Jun Nakagawa; Kosuke Toda; Ryotaro Ogawa; Susumu Inamoto; Rei Mizuno; Yoshiro Itatani; Yoshiharu Sakai
Journal:  Cell Death Dis       Date:  2019-03-19       Impact factor: 8.469

8.  N-methyl-N-nitro-N'-nitrosoguanidine induces the expression of CCR2 in human gastric epithelial cells promoting CCL2-mediated migration.

Authors:  Jie Cai; Mei Wang; Mengchu Zhu; Qiang Zhang; Xu Zhang; Yongmin Yan; Hui Qian; Wenrong Xu
Journal:  Mol Med Rep       Date:  2015-12-07       Impact factor: 2.952

9.  Triphala Suppresses Growth and Migration of Human Gastric Carcinoma Cells In Vitro and in a Zebrafish Xenograft Model.

Authors:  Jokyab Tsering; Xianda Hu
Journal:  Biomed Res Int       Date:  2018-12-10       Impact factor: 3.411

10.  Mouse bone marrow mesenchymal stem cells with distinct p53 statuses display differential characteristics.

Authors:  Bo Wang; Lingxia Wang; Jiahui Mao; Huiyan Wen; Longjiang Xu; Yang Ren; Hong Du; Huan Yang
Journal:  Mol Med Rep       Date:  2020-03-12       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.